One-fourth of transvenous implantable cardioverter defibrillator (ICD) leads has a mechanical complication within 10 years, according to an insurance database analysis published May 10 in the Journal of the American Heart Association.

Left radial access (LRA) for percutaneous coronary intervention (PCI) remains rare in the United Kingdom, according to a registry analysis—but it is associated with similar clinical outcomes as right radial access (RRA) and possibly a reduced risk of stroke.

Patients with stroke-related intracerebral hemorrhage (TICH-2) may benefit from receiving tranexamic acid (TXA), a drug treatment used to treat blood loss from trauma and bleeding after child birth, according to research presented May 16 at the European Stroke Conference in Sweden.

A study published May 8 in the Journal of the American Heart Association suggests black and white patients with heart failure with reduced ejection fraction (HFrEF) derive similar benefit from beta-blockers, despite conflicting previous reports.

Researchers at Imperial College London and the University of Edinburgh have developed machine learning software that detects small vessel disease (SVD)—which can ultimately cause stroke.

Acetaminophen after pediatric heart surgery was associated with an increasingly protective effect against acute kidney injury (AKI), according to an analysis of separate cohorts at two children’s hospitals.

Baylor St. Luke’s Medical Center in Houston continues to tout itself as one of the top heart transplant centers in the country, even as quality measures lag well behind national averages.

The investigators of the anticipated ISCHEMIA trial have published a paper in Circulation: Cardiovascular Quality and Outcomes defending their late addition of “softer” outcomes to their primary composite endpoint.